Abstract

Most people’s cognitive abilities decline with age, with significant and partly genetically driven, individual differences in rate of change. Although APOE ɛ4 and genetic scores for late-onset Alzheimer’s disease (LOAD) have been related to cognitive decline during preclinical stages of dementia, there is limited knowledge concerning genetic factors implied in normal cognitive aging. In the present study, we examined three potential genetic predictors of age-related cognitive decline as follows: (1) the APOE ɛ4 allele, (2) a polygenic score for general cognitive ability (PGS-cog), and (3) a polygenic risk score for late-onset AD (PRS-LOAD). We examined up to six time points of cognitive measurements in the longitudinal population-based Betula study, covering a 25-year follow-up period. Only participants that remained alive and non-demented until the most recent dementia screening (1–3 years after the last test occasion) were included (n = 1087). Individual differences in rate of cognitive change (composite score) were predicted by the PRS-LOAD and APOE ɛ4, but not by PGS-cog. To control for the possibility that the results reflected a preclinical state of Alzheimer’s disease in some participants, we re-ran the analyses excluding cognitive data from the last test occasion to model cognitive change up-until a minimum of 6 years before potential onset of clinical Alzheimers. Strikingly, the association of PRS-LOAD, but not APOE ɛ4, with cognitive change remained. The results indicate that PRS-LOAD predicts individual difference in rate of cognitive decline in normal aging, but it remains to be determined to what extent this reflects preclinical Alzheimer’s disease brain pathophysiology and subsequent risk to develop the disease.

Highlights

  • In normal aging, a pattern of decline is observed across a multitude of cognitive domains, the magnitude differs across domains and individual differences in rate of change are substantial[1,2,3]

  • Using linear mixed-effect models, we examined the association of PGS-Cog, PRS-Lateonset Alzheimer’s disease (LOAD), and APOE ɛ4 on the level and slope of cognitive performance

  • A significant negative association with slope was seen for both PRS-LOAD (p = 0.018 uncorrected) and APOE ɛ4 (p = 0.043, uncorrected), whereas no effect was seen for the PGS-Cog (Table 1)

Read more

Summary

Introduction

A pattern of decline is observed across a multitude of cognitive domains, the magnitude differs across domains and individual differences in rate of change are substantial[1,2,3]. Due to a high societal disease burden of Alzheimer’s disease, much research is Between-person variability in level of cognitive functioning is largely dependent on genetic factors, with twin heritability estimates ranging from 50 to 80%13,14 and modest differences in heritability of cognitive level at different age groups[15]. As few studies involved largescale longitudinal data on cognitive aging and genetics, the specific genetic factors underlying normal cognitive aging remain to be further investigated. It is unknown whether there is genetic overlap between normal age-related cognitive decline and Alzheimer’s disease

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.